It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has ...

Globus Medical (GMED) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.

Products to Support the Adoption of Droplet Digital PCR in Oncology In a key regulatory milestone, Bio-Rad has obtained In ...

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two companies is the best ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Amalgamated Bank trimmed its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.4% in the third quarter, ...

Wells Fargo has recently raised Globus Medical Inc (GMED) stock to Overweight rating, as announced on August 7, 2024, according to Finviz. Earlier, on May 20, 2024, Piper Sandler had raised the stock ...

Truist Financial analyst Richard Newitter maintained a Hold rating on Globus Medical (GMED – Research Report) today and set a price ...

Operator Welcome to Globus Medical's third quarter 2024 earnings call. At this time, all lines will be on mute and a Q&A ...